Severe ICANS after CAR T-cell therapy and assessment of prevention with levetiracetam for seizure prophylaxis following CAR T-cell for DLBCL & PMBCL in Europe: a survey on behalf of the Cellular Therapy & Immunobiology Working Party (CTIWP) of the EBMT.

Angelillo, PieraPieraAngelilloAlarcon Tomas, AnaAnaAlarcon TomasCampodonico, EdoardoEdoardoCampodonicoNovak, UrbanUrbanNovakGabellier, LudovicLudovicGabellierBlau, Igor WolfgangIgor WolfgangBlauKwon, MiMiKwonRam, RonRonRamForcade, EdouardEdouardForcadeBesley, CarolineCarolineBesleyVucinic, VladanVladanVucinicKröger, NicolausNicolausKrögerCorral, Lucía LópezLucía LópezCorralVydra, JanJanVydraFerrari, SilviaSilviaFerrarivon Tresckow, BastianBastianvon TresckowRubio, Marie ThereseMarie ThereseRubioHernani, RafaelRafaelHernaniSica, SimonaSimonaSicaStölzel, FriedrichFriedrichStölzelRovira, MontserratMontserratRoviraWagner-Drouet, EvaEvaWagner-DrouetPérez-Simón, Jose AntonioJose AntonioPérez-SimónCastilla-Llorente, CristinaCristinaCastilla-LlorenteFerreri, Andres J MAndres J MFerreriHoogenboom, Jorinde DJorinde DHoogenboomSanchez Ortega, IsabelIsabelSanchez OrtegaMalard, FlorentFlorentMalardKuball, JürgenJürgenKuballRuggeri, AnnalisaAnnalisaRuggeri2024-12-032024-12-032025-01https://boris-portal.unibe.ch/handle/20.500.12422/189438en600 - Technology::610 - Medicine & healthSevere ICANS after CAR T-cell therapy and assessment of prevention with levetiracetam for seizure prophylaxis following CAR T-cell for DLBCL & PMBCL in Europe: a survey on behalf of the Cellular Therapy & Immunobiology Working Party (CTIWP) of the EBMT.article10.48620/771253945589610.1038/s41409-024-02451-8